177 related articles for article (PubMed ID: 33595155)
1. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
[TBL] [Abstract][Full Text] [Related]
2. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Williams JL; Patel JR; Daniels BP; Klein RS
J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
[TBL] [Abstract][Full Text] [Related]
3. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.
Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301
[TBL] [Abstract][Full Text] [Related]
4. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
5. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.
Liu L; Darnall L; Hu T; Choi K; Lane TE; Ransohoff RM
J Neurosci; 2010 Jul; 30(27):9074-83. PubMed ID: 20610741
[TBL] [Abstract][Full Text] [Related]
6. ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects.
Pouzol L; Sassi A; Tunis M; Zurbach A; Baumlin N; Gnerre C; Strasser DS; Marrie J; Vezzali E; Martinic MM
Neurochem Res; 2024 May; ():. PubMed ID: 38819698
[TBL] [Abstract][Full Text] [Related]
7. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
8. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
[TBL] [Abstract][Full Text] [Related]
9. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M
Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941
[TBL] [Abstract][Full Text] [Related]
10. A regenerative approach to the treatment of multiple sclerosis.
Deshmukh VA; Tardif V; Lyssiotis CA; Green CC; Kerman B; Kim HJ; Padmanabhan K; Swoboda JG; Ahmad I; Kondo T; Gage FH; Theofilopoulos AN; Lawson BR; Schultz PG; Lairson LL
Nature; 2013 Oct; 502(7471):327-332. PubMed ID: 24107995
[TBL] [Abstract][Full Text] [Related]
11. Activation of CXCR7 receptor promotes oligodendroglial cell maturation.
Göttle P; Kremer D; Jander S; Odemis V; Engele J; Hartung HP; Küry P
Ann Neurol; 2010 Dec; 68(6):915-24. PubMed ID: 21154415
[TBL] [Abstract][Full Text] [Related]
12. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
13. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
14. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair.
Liu L; Du X; Yang Q; Li M; Ran Q; Liu Q; Yang L; Sun L; Guo Y; Li Y; Chen Y; Zhu X; Li Q
Phytomedicine; 2022 Nov; 106():154309. PubMed ID: 35994846
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
[TBL] [Abstract][Full Text] [Related]
17. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
18. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
Lin Y; Huang G; Jamison S; Li J; Harding HP; Ron D; Lin W
Am J Pathol; 2014 Feb; 184(2):507-19. PubMed ID: 24269558
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis.
Poon MM; Lorrain KI; Stebbins KJ; Edu GC; Broadhead AR; Lorenzana AO; Paulson BE; Baccei CS; Roppe JR; Schrader TO; Valdez LJ; Xiong Y; Chen AC; Lorrain DS
Sci Rep; 2024 May; 14(1):10573. PubMed ID: 38719983
[TBL] [Abstract][Full Text] [Related]
20. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity.
Cruz-Orengo L; Chen YJ; Kim JH; Dorsey D; Song SK; Klein RS
J Neuroinflammation; 2011 Dec; 8():170. PubMed ID: 22145790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
